<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-05-10" version="190">
<accession>P55072</accession>
<accession>B2R5T8</accession>
<accession>Q0V924</accession>
<accession>Q2TAI5</accession>
<accession>Q969G7</accession>
<accession>Q9UCD5</accession>
<name>TERA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Transitional endoplasmic reticulum ATPase</fullName>
<shortName>TER ATPase</shortName>
<ecNumber evidence="71">3.6.4.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>15S Mg(2+)-ATPase p97 subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Valosin-containing protein</fullName>
<shortName>VCP</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">VCP</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1998-03" db="EMBL/GenBank/DDBJ databases">
<title>Sequence analysis of a human P1 clone containing the XRCC9 DNA repair gene.</title>
<authorList>
<person name="Lamerdin J.E."/>
<person name="McCready P.M."/>
<person name="Skowronski E."/>
<person name="Adamson A.W."/>
<person name="Burkhart-Schultz K."/>
<person name="Gordon L."/>
<person name="Kyle A."/>
<person name="Ramirez M."/>
<person name="Stilwagen S."/>
<person name="Phan H."/>
<person name="Velasco N."/>
<person name="Garnes J."/>
<person name="Danganan L."/>
<person name="Poundstone P."/>
<person name="Christensen M."/>
<person name="Georgescu A."/>
<person name="Avila J."/>
<person name="Liu S."/>
<person name="Attix C."/>
<person name="Andreise T."/>
<person name="Trankheim M."/>
<person name="Amico-Keller G."/>
<person name="Coefield J."/>
<person name="Duarte S."/>
<person name="Lucas S."/>
<person name="Bruce R."/>
<person name="Thomas P."/>
<person name="Quan G."/>
<person name="Kronmiller B."/>
<person name="Arellano A."/>
<person name="Montgomery M."/>
<person name="Ow D."/>
<person name="Nolan M."/>
<person name="Trong S."/>
<person name="Kobayashi A."/>
<person name="Olsen A.O."/>
<person name="Carrano A.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="9543" last="9548">
<title>Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.</title>
<authorList>
<person name="Hu R.-M."/>
<person name="Han Z.-G."/>
<person name="Song H.-D."/>
<person name="Peng Y.-D."/>
<person name="Huang Q.-H."/>
<person name="Ren S.-X."/>
<person name="Gu Y.-J."/>
<person name="Huang C.-H."/>
<person name="Li Y.-B."/>
<person name="Jiang C.-L."/>
<person name="Fu G."/>
<person name="Zhang Q.-H."/>
<person name="Gu B.-W."/>
<person name="Dai M."/>
<person name="Mao Y.-F."/>
<person name="Gao G.-F."/>
<person name="Rong R."/>
<person name="Ye M."/>
<person name="Zhou J."/>
<person name="Xu S.-H."/>
<person name="Gu J."/>
<person name="Shi J.-X."/>
<person name="Jin W.-R."/>
<person name="Zhang C.-K."/>
<person name="Wu T.-M."/>
<person name="Huang G.-Y."/>
<person name="Chen Z."/>
<person name="Chen M.-D."/>
<person name="Chen J.-L."/>
</authorList>
<dbReference type="PubMed" id="10931946"/>
<dbReference type="DOI" id="10.1073/pnas.160270997"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pituitary</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="566" last="569">
<title>Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.</title>
<authorList>
<person name="Gevaert K."/>
<person name="Goethals M."/>
<person name="Martens L."/>
<person name="Van Damme J."/>
<person name="Staes A."/>
<person name="Thomas G.R."/>
<person name="Vandekerckhove J."/>
</authorList>
<dbReference type="PubMed" id="12665801"/>
<dbReference type="DOI" id="10.1038/nbt810"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-25</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2005-11" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Claeys D."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-18; 148-155; 278-287; 296-312; 366-377; 466-487; 587-599; 639-651 AND 669-677</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Nature" volume="365" first="459" last="462">
<title>Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein.</title>
<authorList>
<person name="Pleasure I.T."/>
<person name="Black M.M."/>
<person name="Keen J.H."/>
</authorList>
<dbReference type="PubMed" id="8413590"/>
<dbReference type="DOI" id="10.1038/365459a0"/>
</citation>
<scope>PROTEIN SEQUENCE OF 27-41 AND 233-238</scope>
<scope>INTERACTION WITH CLATHRIN</scope>
<source>
<tissue>Glial tumor</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 46-53; 66-81; 96-109; 148-155; 240-251; 323-336; 454-502; 530-560; 600-614; 639-651; 678-693; 714-732 AND 754-766</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2013" name="PLoS Genet." volume="9" first="E1003210" last="E1003210">
<title>A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity.</title>
<authorList>
<person name="Cloutier P."/>
<person name="Lavallee-Adam M."/>
<person name="Faubert D."/>
<person name="Blanchette M."/>
<person name="Coulombe B."/>
</authorList>
<dbReference type="PubMed" id="23349634"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1003210"/>
</citation>
<scope>PROTEIN SEQUENCE OF 314-322</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>METHYLATION AT LYS-315</scope>
<scope>MUTAGENESIS OF LYS-315</scope>
<scope>CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155 AND GLN-191</scope>
<scope>CHARACTERIZATION OF VARIANT ALS14 GLY-159</scope>
</reference>
<reference key="12">
<citation type="submission" date="1996-04" db="EMBL/GenBank/DDBJ databases">
<title>Characterization of different mRNA types expressed in human brain.</title>
<authorList>
<person name="Dmitrenko V.V."/>
<person name="Garifulin O.M."/>
<person name="Kavsan V.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 388-483</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Biochem. J." volume="384" first="391" last="400">
<title>A novel UBA and UBX domain protein that binds polyubiquitin and VCP and is a substrate for SAPKs.</title>
<authorList>
<person name="McNeill H."/>
<person name="Knebel A."/>
<person name="Arthur J.S."/>
<person name="Cuenda A."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="15362974"/>
<dbReference type="DOI" id="10.1042/BJ20041498"/>
</citation>
<scope>INTERACTION WITH NGLY1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51376" last="51385">
<title>Physical and functional interaction between dorfin and valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders.</title>
<authorList>
<person name="Ishigaki S."/>
<person name="Hishikawa N."/>
<person name="Niwa J."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Hori S."/>
<person name="Kakizuka A."/>
<person name="Tanaka K."/>
<person name="Sobue G."/>
</authorList>
<dbReference type="PubMed" id="15456787"/>
<dbReference type="DOI" id="10.1074/jbc.M406683200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RNF19A</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-524</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Nature" volume="429" first="841" last="847">
<title>A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol.</title>
<authorList>
<person name="Ye Y."/>
<person name="Shibata Y."/>
<person name="Yun C."/>
<person name="Ron D."/>
<person name="Rapoport T.A."/>
</authorList>
<dbReference type="PubMed" id="15215856"/>
<dbReference type="DOI" id="10.1038/nature02656"/>
</citation>
<scope>INTERACTION WITH SELENOS</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
<title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
<authorList>
<person name="Giannakopoulos N.V."/>
<person name="Luo J.K."/>
<person name="Papov V."/>
<person name="Zou W."/>
<person name="Lenschow D.J."/>
<person name="Jacobs B.S."/>
<person name="Borden E.C."/>
<person name="Li J."/>
<person name="Virgin H.W."/>
<person name="Zhang D.E."/>
</authorList>
<dbReference type="PubMed" id="16139798"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="354" first="1021" last="1027">
<title>The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway.</title>
<authorList>
<person name="Schulze A."/>
<person name="Standera S."/>
<person name="Buerger E."/>
<person name="Kikkert M."/>
<person name="van Voorden S."/>
<person name="Wiertz E."/>
<person name="Koning F."/>
<person name="Kloetzel P.-M."/>
<person name="Seeger M."/>
</authorList>
<dbReference type="PubMed" id="16289116"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.10.020"/>
</citation>
<scope>INTERACTION WITH SYVN1 AND DERL1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Cell" volume="19" first="829" last="840">
<title>Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase.</title>
<authorList>
<person name="Song B.L."/>
<person name="Sever N."/>
<person name="DeBose-Boyd R.A."/>
</authorList>
<dbReference type="PubMed" id="16168377"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.08.009"/>
</citation>
<scope>INTERACTION WITH AMFR</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-251 AND LYS-524</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="14132" last="14138">
<title>Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane.</title>
<authorList>
<person name="Ye Y."/>
<person name="Shibata Y."/>
<person name="Kikkert M."/>
<person name="van Voorden S."/>
<person name="Wiertz E."/>
<person name="Rapoport T.A."/>
</authorList>
<dbReference type="PubMed" id="16186510"/>
<dbReference type="DOI" id="10.1073/pnas.0505006102"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DERL1; AMFR; SYVN1 AND SELENOS</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="14296" last="14301">
<title>Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane.</title>
<authorList>
<person name="Lilley B.N."/>
<person name="Ploegh H.L."/>
</authorList>
<dbReference type="PubMed" id="16186509"/>
<dbReference type="DOI" id="10.1073/pnas.0505014102"/>
</citation>
<scope>INTERACTION WITH DERL1 AND DERL2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="11610" last="11617">
<title>Calcium-sensing receptor ubiquitination and degradation mediated by the E3 ubiquitin ligase dorfin.</title>
<authorList>
<person name="Huang Y."/>
<person name="Niwa J."/>
<person name="Sobue G."/>
<person name="Breitwieser G.E."/>
</authorList>
<dbReference type="PubMed" id="16513638"/>
<dbReference type="DOI" id="10.1074/jbc.M513552200"/>
</citation>
<scope>INTERACTION WITH CASR AND RNF19A</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="J. Cell Biol." volume="172" first="383" last="393">
<title>Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation.</title>
<authorList>
<person name="Oda Y."/>
<person name="Okada T."/>
<person name="Yoshida H."/>
<person name="Kaufman R.J."/>
<person name="Nagata K."/>
<person name="Mori K."/>
</authorList>
<dbReference type="PubMed" id="16449189"/>
<dbReference type="DOI" id="10.1083/jcb.200507057"/>
</citation>
<scope>INTERACTION WITH DERL1; DERL2 AND DERL3</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="J. Cell Sci." volume="119" first="4011" last="4024">
<title>Characterization of erasin (UBXD2): a new ER protein that promotes ER-associated protein degradation.</title>
<authorList>
<person name="Liang J."/>
<person name="Yin C."/>
<person name="Doong H."/>
<person name="Fang S."/>
<person name="Peterhoff C."/>
<person name="Nixon R.A."/>
<person name="Monteiro M.J."/>
</authorList>
<dbReference type="PubMed" id="16968747"/>
<dbReference type="DOI" id="10.1242/jcs.03163"/>
</citation>
<scope>INTERACTION WITH UBXN4</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="1670" last="1682">
<title>The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD.</title>
<authorList>
<person name="Lerner M."/>
<person name="Corcoran M."/>
<person name="Cepeda D."/>
<person name="Nielsen M.L."/>
<person name="Zubarev R."/>
<person name="Ponten F."/>
<person name="Uhlen M."/>
<person name="Hober S."/>
<person name="Grander D."/>
<person name="Sangfelt O."/>
</authorList>
<dbReference type="PubMed" id="17314412"/>
<dbReference type="DOI" id="10.1091/mbc.E06-03-0248"/>
</citation>
<scope>INTERACTION WITH TRIM13</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="374" first="737" last="741">
<title>Ubiquitin ligase Kf-1 is involved in the endoplasmic reticulum-associated degradation pathway.</title>
<authorList>
<person name="Maruyama Y."/>
<person name="Yamada M."/>
<person name="Takahashi K."/>
<person name="Yamada M."/>
</authorList>
<dbReference type="PubMed" id="18675248"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.07.126"/>
</citation>
<scope>INTERACTION WITH RNF103</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Int. J. Biochem. Cell Biol." volume="40" first="2927" last="2942">
<title>Ubxd1 is a novel co-factor of the human p97 ATPase.</title>
<authorList>
<person name="Madsen L."/>
<person name="Andersen K.M."/>
<person name="Prag S."/>
<person name="Moos T."/>
<person name="Semple C.A."/>
<person name="Seeger M."/>
<person name="Hartmann-Petersen R."/>
</authorList>
<dbReference type="PubMed" id="18656546"/>
<dbReference type="DOI" id="10.1016/j.biocel.2008.06.008"/>
</citation>
<scope>INTERACTION WITH UBXN6</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; THR-436 AND SER-787</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Mol. Immunol." volume="45" first="2045" last="2054">
<title>Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system.</title>
<authorList>
<person name="Takahata M."/>
<person name="Bohgaki M."/>
<person name="Tsukiyama T."/>
<person name="Kondo T."/>
<person name="Asaka M."/>
<person name="Hatakeyama S."/>
</authorList>
<dbReference type="PubMed" id="18022694"/>
<dbReference type="DOI" id="10.1016/j.molimm.2007.10.023"/>
</citation>
<scope>INTERACTION WITH TRIM21</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="J. Cell Biol." volume="187" first="201" last="217">
<title>Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD.</title>
<authorList>
<person name="Lim P.J."/>
<person name="Danner R."/>
<person name="Liang J."/>
<person name="Doong H."/>
<person name="Harman C."/>
<person name="Srinivasan D."/>
<person name="Rothenberg C."/>
<person name="Wang H."/>
<person name="Ye Y."/>
<person name="Fang S."/>
<person name="Monteiro M.J."/>
</authorList>
<dbReference type="PubMed" id="19822669"/>
<dbReference type="DOI" id="10.1083/jcb.200903024"/>
</citation>
<scope>INTERACTION WITH UBXN4</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH UBQLN1 AND UBXN4</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="28" last="38">
<title>The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER.</title>
<authorList>
<person name="Ernst R."/>
<person name="Mueller B."/>
<person name="Ploegh H.L."/>
<person name="Schlieker C."/>
</authorList>
<dbReference type="PubMed" id="19818707"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.09.016"/>
</citation>
<scope>INTERACTION WITH YOD1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND SER-37</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-770 AND SER-775</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Brain" volume="133" first="2920" last="2941">
<title>Strumpellin is a novel valosin-containing protein binding partner linking hereditary spastic paraplegia to protein aggregation diseases.</title>
<authorList>
<person name="Clemen C.S."/>
<person name="Tangavelou K."/>
<person name="Strucksberg K.H."/>
<person name="Just S."/>
<person name="Gaertner L."/>
<person name="Regus-Leidig H."/>
<person name="Stumpf M."/>
<person name="Reimann J."/>
<person name="Coras R."/>
<person name="Morgan R.O."/>
<person name="Fernandez M.P."/>
<person name="Hofmann A."/>
<person name="Muller S."/>
<person name="Schoser B."/>
<person name="Hanisch F.G."/>
<person name="Rottbauer W."/>
<person name="Blumcke I."/>
<person name="von Horsten S."/>
<person name="Eichinger L."/>
<person name="Schroder R."/>
</authorList>
<dbReference type="PubMed" id="20833645"/>
<dbReference type="DOI" id="10.1093/brain/awq222"/>
</citation>
<scope>INTERACTION WITH WASHC5</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Mol. Biol. Cell" volume="22" first="291" last="300">
<title>The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover.</title>
<authorList>
<person name="Xu S."/>
<person name="Peng G."/>
<person name="Wang Y."/>
<person name="Fang S."/>
<person name="Karbowski M."/>
</authorList>
<dbReference type="PubMed" id="21118995"/>
<dbReference type="DOI" id="10.1091/mbc.E10-09-0748"/>
</citation>
<scope>FUNCTION IN OMM PROTEIN TURNOVER</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="758" last="770">
<title>A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation.</title>
<authorList>
<person name="Wang Q."/>
<person name="Liu Y."/>
<person name="Soetandyo N."/>
<person name="Baek K."/>
<person name="Hegde R."/>
<person name="Ye Y."/>
</authorList>
<dbReference type="PubMed" id="21636303"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.05.010"/>
</citation>
<scope>INTERACTION WITH BAG6</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E25061" last="E25061">
<title>The tissue-specific Rep8/UBXD6 tethers p97 to the endoplasmic reticulum membrane for degradation of misfolded proteins.</title>
<authorList>
<person name="Madsen L."/>
<person name="Kriegenburg F."/>
<person name="Vala A."/>
<person name="Best D."/>
<person name="Prag S."/>
<person name="Hofmann K."/>
<person name="Seeger M."/>
<person name="Adams I.R."/>
<person name="Hartmann-Petersen R."/>
</authorList>
<dbReference type="PubMed" id="21949850"/>
<dbReference type="DOI" id="10.1371/journal.pone.0025061"/>
</citation>
<scope>INTERACTION WITH UBXN8</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="BMC Biol." volume="10" first="36" last="36">
<title>UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1alpha accumulation.</title>
<authorList>
<person name="Bandau S."/>
<person name="Knebel A."/>
<person name="Gage Z.O."/>
<person name="Wood N.T."/>
<person name="Alexandru G."/>
</authorList>
<dbReference type="PubMed" id="22537386"/>
<dbReference type="DOI" id="10.1186/1741-7007-10-36"/>
</citation>
<scope>INTERACTION WITH UBXN7</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Mol. Cell" volume="47" first="558" last="569">
<title>Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins.</title>
<authorList>
<person name="Fleig L."/>
<person name="Bergbold N."/>
<person name="Sahasrabudhe P."/>
<person name="Geiger B."/>
<person name="Kaltak L."/>
<person name="Lemberg M.K."/>
</authorList>
<dbReference type="PubMed" id="22795130"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.06.008"/>
</citation>
<scope>INTERACTION WITH RHBDD1</scope>
<scope>MUTAGENESIS OF LYS-251; LYS-524 AND GLU-578</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Nat. Cell Biol." volume="13" first="1376" last="1382">
<title>The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks.</title>
<authorList>
<person name="Meerang M."/>
<person name="Ritz D."/>
<person name="Paliwal S."/>
<person name="Garajova Z."/>
<person name="Bosshard M."/>
<person name="Mailand N."/>
<person name="Janscak P."/>
<person name="Hubscher U."/>
<person name="Meyer H."/>
<person name="Ramadan K."/>
</authorList>
<dbReference type="PubMed" id="22020440"/>
<dbReference type="DOI" id="10.1038/ncb2367"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="Nat. Struct. Mol. Biol." volume="18" first="1345" last="1350">
<title>The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks.</title>
<authorList>
<person name="Acs K."/>
<person name="Luijsterburg M.S."/>
<person name="Ackermann L."/>
<person name="Salomons F.A."/>
<person name="Hoppe T."/>
<person name="Dantuma N.P."/>
</authorList>
<dbReference type="PubMed" id="22120668"/>
<dbReference type="DOI" id="10.1038/nsmb.2188"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH L3MBTL1</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="34225" last="34233">
<title>Proliferating cell nuclear antigen (PCNA)-binding protein C1orf124 is a regulator of translesion synthesis.</title>
<authorList>
<person name="Ghosal G."/>
<person name="Leung J.W."/>
<person name="Nair B.C."/>
<person name="Fong K.W."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="22902628"/>
<dbReference type="DOI" id="10.1074/jbc.M112.400135"/>
</citation>
<scope>INTERACTION WITH SPRTN</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2012" name="Mol. Cell" volume="47" first="99" last="110">
<title>STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein.</title>
<authorList>
<person name="Sato T."/>
<person name="Sako Y."/>
<person name="Sho M."/>
<person name="Momohara M."/>
<person name="Suico M.A."/>
<person name="Shuto T."/>
<person name="Nishitoh H."/>
<person name="Okiyoneda T."/>
<person name="Kokame K."/>
<person name="Kaneko M."/>
<person name="Taura M."/>
<person name="Miyata M."/>
<person name="Chosa K."/>
<person name="Koga T."/>
<person name="Morino-Koga S."/>
<person name="Wada I."/>
<person name="Kai H."/>
</authorList>
<dbReference type="PubMed" id="22607976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.04.015"/>
</citation>
<scope>FUNCTION IN ERAD PATHWAY</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2012" name="Nat. Commun." volume="3" first="1038" last="1038">
<title>Lysine methylation of VCP by a member of a novel human protein methyltransferase family.</title>
<authorList>
<person name="Kernstock S."/>
<person name="Davydova E."/>
<person name="Jakobsson M."/>
<person name="Moen A."/>
<person name="Pettersen S."/>
<person name="Maelandsmo G.M."/>
<person name="Egge-Jacobsen W."/>
<person name="Falnes P.O."/>
</authorList>
<dbReference type="PubMed" id="22948820"/>
<dbReference type="DOI" id="10.1038/ncomms2041"/>
</citation>
<scope>METHYLATION AT LYS-315</scope>
<scope>MUTAGENESIS OF LYS-312; ARG-313; GLU-314; LYS-315; THR-316; HIS-317 AND GLY-318</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="1093" last="1100">
<title>DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage.</title>
<authorList>
<person name="Davis E.J."/>
<person name="Lachaud C."/>
<person name="Appleton P."/>
<person name="Macartney T.J."/>
<person name="Nathke I."/>
<person name="Rouse J."/>
</authorList>
<dbReference type="PubMed" id="23042607"/>
<dbReference type="DOI" id="10.1038/nsmb.2394"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SPRTN</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="1084" last="1092">
<title>DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks.</title>
<authorList>
<person name="Mosbech A."/>
<person name="Gibbs-Seymour I."/>
<person name="Kagias K."/>
<person name="Thorslund T."/>
<person name="Beli P."/>
<person name="Povlsen L."/>
<person name="Nielsen S.V."/>
<person name="Smedegaard S."/>
<person name="Sedgwick G."/>
<person name="Lukas C."/>
<person name="Hartmann-Petersen R."/>
<person name="Lukas J."/>
<person name="Choudhary C."/>
<person name="Pocock R."/>
<person name="Bekker-Jensen S."/>
<person name="Mailand N."/>
</authorList>
<dbReference type="PubMed" id="23042605"/>
<dbReference type="DOI" id="10.1038/nsmb.2395"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SPRTN</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-7; SER-13; SER-462 AND SER-702</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="53">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="54">
<citation type="journal article" date="2014" name="Mol. Cell" volume="54" first="349" last="361">
<title>Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB signaling.</title>
<authorList>
<person name="Schaeffer V."/>
<person name="Akutsu M."/>
<person name="Olma M.H."/>
<person name="Gomes L.C."/>
<person name="Kawasaki M."/>
<person name="Dikic I."/>
</authorList>
<dbReference type="PubMed" id="24726327"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.03.016"/>
</citation>
<scope>INTERACTION WITH RNF31</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2015" name="Cell Rep." volume="13" first="944" last="956">
<title>Pre-emptive quality control protects the ER from protein overload via the proximity of ERAD components and SRP.</title>
<authorList>
<person name="Kadowaki H."/>
<person name="Nagai A."/>
<person name="Maruyama T."/>
<person name="Takami Y."/>
<person name="Satrimafitrah P."/>
<person name="Kato H."/>
<person name="Honda A."/>
<person name="Hatta T."/>
<person name="Natsume T."/>
<person name="Sato T."/>
<person name="Kai H."/>
<person name="Ichijo H."/>
<person name="Nishitoh H."/>
</authorList>
<dbReference type="PubMed" id="26565908"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.09.047"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2015" name="EMBO J." volume="34" first="2903" last="2920">
<title>A non-canonical role of the p97 complex in RIG-I antiviral signaling.</title>
<authorList>
<person name="Hao Q."/>
<person name="Jiao S."/>
<person name="Shi Z."/>
<person name="Li C."/>
<person name="Meng X."/>
<person name="Zhang Z."/>
<person name="Wang Y."/>
<person name="Song X."/>
<person name="Wang W."/>
<person name="Zhang R."/>
<person name="Zhao Y."/>
<person name="Wong C.C."/>
<person name="Zhou Z."/>
</authorList>
<dbReference type="PubMed" id="26471729"/>
<dbReference type="DOI" id="10.15252/embj.201591888"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH DDX58 AND RNF125</scope>
<scope>MUTAGENESIS OF 52-PHE--ASP-55; TYR-110; GLU-305 AND GLU-578</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2010" name="EMBO J." volume="29" first="2217" last="2229">
<title>A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants.</title>
<authorList>
<person name="Tang W.K."/>
<person name="Li D."/>
<person name="Li C.C."/>
<person name="Esser L."/>
<person name="Dai R."/>
<person name="Guo L."/>
<person name="Xia D."/>
</authorList>
<dbReference type="PubMed" id="20512113"/>
<dbReference type="DOI" id="10.1038/emboj.2010.104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-481 IN COMPLEX WITH ATP ANALOG</scope>
<scope>CHARACTERIZATION OF VARIANTS IBMPFD1 GLY-95 AND HIS-155</scope>
<scope>MUTAGENESIS OF ARG-53 AND ARG-86</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="365" last="372">
<title>Structure and function of the PLAA/Ufd3-p97/Cdc48 complex.</title>
<authorList>
<person name="Qiu L."/>
<person name="Pashkova N."/>
<person name="Walker J.R."/>
<person name="Winistorfer S."/>
<person name="Allali-Hassani A."/>
<person name="Akutsu M."/>
<person name="Piper R."/>
<person name="Dhe-Paganon S."/>
</authorList>
<dbReference type="PubMed" id="19887378"/>
<dbReference type="DOI" id="10.1074/jbc.M109.044685"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 797-806 IN COMPLEX WITH PLAA</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="38679" last="38690">
<title>The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97.</title>
<authorList>
<person name="Hanzelmann P."/>
<person name="Schindelin H."/>
</authorList>
<dbReference type="PubMed" id="21914798"/>
<dbReference type="DOI" id="10.1074/jbc.M111.274506"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-187 IN COMPLEX WITH AMFR</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="377" last="381">
<title>Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.</title>
<authorList>
<person name="Watts G.D.J."/>
<person name="Wymer J."/>
<person name="Kovach M.J."/>
<person name="Mehta S.G."/>
<person name="Mumm S."/>
<person name="Darvish D."/>
<person name="Pestronk A."/>
<person name="Whyte M.P."/>
<person name="Kimonis V.E."/>
</authorList>
<dbReference type="PubMed" id="15034582"/>
<dbReference type="DOI" id="10.1038/ng1332"/>
</citation>
<scope>VARIANTS IBMPFD1 GLY-95; CYS-155; HIS-155; PRO-155; GLN-191 AND GLU-232</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2005" name="Ann. Neurol." volume="57" first="457" last="461">
<title>Mutant valosin-containing protein causes a novel type of frontotemporal dementia.</title>
<authorList>
<person name="Schroeder R."/>
<person name="Watts G.D.J."/>
<person name="Mehta S.G."/>
<person name="Evert B.O."/>
<person name="Broich P."/>
<person name="Fliessbach K."/>
<person name="Pauls K."/>
<person name="Hans V.H."/>
<person name="Kimonis V."/>
<person name="Thal D.R."/>
</authorList>
<dbReference type="PubMed" id="15732117"/>
<dbReference type="DOI" id="10.1002/ana.20407"/>
</citation>
<scope>VARIANT IBMPFD1 CYS-155</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2005" name="Neurology" volume="65" first="1304" last="1305">
<title>Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene.</title>
<authorList>
<person name="Haubenberger D."/>
<person name="Bittner R.E."/>
<person name="Rauch-Shorny S."/>
<person name="Zimprich F."/>
<person name="Mannhalter C."/>
<person name="Wagner L."/>
<person name="Mineva I."/>
<person name="Vass K."/>
<person name="Auff E."/>
<person name="Zimprich A."/>
</authorList>
<dbReference type="PubMed" id="16247064"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000180407.15369.92"/>
</citation>
<scope>VARIANT IBMPFD1 HIS-159</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2006" name="Hum. Mol. Genet." volume="15" first="189" last="199">
<title>Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.</title>
<authorList>
<person name="Weihl C.C."/>
<person name="Dalal S."/>
<person name="Pestronk A."/>
<person name="Hanson P.I."/>
</authorList>
<dbReference type="PubMed" id="16321991"/>
<dbReference type="DOI" id="10.1093/hmg/ddi426"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS IBMPFD1 GLY-95 AND HIS-155</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="Autophagy" volume="6" first="217" last="227">
<title>VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.</title>
<authorList>
<person name="Tresse E."/>
<person name="Salomons F.A."/>
<person name="Vesa J."/>
<person name="Bott L.C."/>
<person name="Kimonis V."/>
<person name="Yao T.P."/>
<person name="Dantuma N.P."/>
<person name="Taylor J.P."/>
</authorList>
<dbReference type="PubMed" id="20104022"/>
<dbReference type="DOI" id="10.4161/auto.6.2.11014"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155; SER-155 AND GLU-232</scope>
<scope>MUTAGENESIS OF GLU-305 AND GLU-578</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2010" name="Neuron" volume="68" first="857" last="864">
<title>Exome sequencing reveals VCP mutations as a cause of familial ALS.</title>
<authorList>
<person name="Johnson J.O."/>
<person name="Mandrioli J."/>
<person name="Benatar M."/>
<person name="Abramzon Y."/>
<person name="Van Deerlin V.M."/>
<person name="Trojanowski J.Q."/>
<person name="Gibbs J.R."/>
<person name="Brunetti M."/>
<person name="Gronka S."/>
<person name="Wuu J."/>
<person name="Ding J."/>
<person name="McCluskey L."/>
<person name="Martinez-Lage M."/>
<person name="Falcone D."/>
<person name="Hernandez D.G."/>
<person name="Arepalli S."/>
<person name="Chong S."/>
<person name="Schymick J.C."/>
<person name="Rothstein J."/>
<person name="Landi F."/>
<person name="Wang Y.D."/>
<person name="Calvo A."/>
<person name="Mora G."/>
<person name="Sabatelli M."/>
<person name="Monsurro M.R."/>
<person name="Battistini S."/>
<person name="Salvi F."/>
<person name="Spataro R."/>
<person name="Sola P."/>
<person name="Borghero G."/>
<person name="Galassi G."/>
<person name="Scholz S.W."/>
<person name="Taylor J.P."/>
<person name="Restagno G."/>
<person name="Chio A."/>
<person name="Traynor B.J."/>
</authorList>
<dbReference type="PubMed" id="21145000"/>
<dbReference type="DOI" id="10.1016/j.neuron.2010.11.036"/>
</citation>
<scope>VARIANTS ALS14 HIS-155; GLY-159; GLN-191 AND ASN-592</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2014" name="Brain" volume="137" first="2897" last="2902">
<title>A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease.</title>
<authorList>
<person name="Gonzalez M.A."/>
<person name="Feely S.M."/>
<person name="Speziani F."/>
<person name="Strickland A.V."/>
<person name="Danzi M."/>
<person name="Bacon C."/>
<person name="Lee Y."/>
<person name="Chou T.F."/>
<person name="Blanton S.H."/>
<person name="Weihl C.C."/>
<person name="Zuchner S."/>
<person name="Shy M.E."/>
</authorList>
<dbReference type="PubMed" id="25125609"/>
<dbReference type="DOI" id="10.1093/brain/awu224"/>
</citation>
<scope>VARIANT CMT2Y LYS-185</scope>
<scope>CHARACTERIZATION OF VARIANT CMT2Y LYS-185</scope>
<scope>CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155 AND GLU-232</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2015" name="Case. Rep. Genet." volume="2015" first="239167" last="239167">
<title>Rare Manifestation of a c.290 C>T, p.Gly97Glu VCP Mutation.</title>
<authorList>
<person name="Jerath N.U."/>
<person name="Crockett C.D."/>
<person name="Moore S.A."/>
<person name="Shy M.E."/>
<person name="Weihl C.C."/>
<person name="Chou T.F."/>
<person name="Grider T."/>
<person name="Gonzalez M.A."/>
<person name="Zuchner S."/>
<person name="Swenson A."/>
</authorList>
<dbReference type="PubMed" id="25878907"/>
<dbReference type="DOI" id="10.1155/2015/239167"/>
</citation>
<scope>VARIANT CMT2Y GLU-97</scope>
<scope>CHARACTERIZATION OF VARIANT CMT2Y GLU-97</scope>
<scope>CHARACTERIZATION OF VARIANTS IBMPFD1 HIS-155 AND GLU-232</scope>
<scope>CHARACTERIZATION OF VARIANT TRP-198</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2016" name="Neuromuscul. Disord." volume="26" first="436" last="440">
<title>Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene.</title>
<authorList>
<person name="Matsubara S."/>
<person name="Shimizu T."/>
<person name="Komori T."/>
<person name="Mori-Yoshimura M."/>
<person name="Minami N."/>
<person name="Hayashi Y.K."/>
</authorList>
<dbReference type="PubMed" id="27209344"/>
<dbReference type="DOI" id="10.1016/j.nmd.2016.05.001"/>
</citation>
<scope>VARIANT IBMPFD1 PHE-126</scope>
</reference>
<comment type="function">
<text evidence="31 34 36 50 53 58 59 61 65 66 71 72">Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and NPLOC4 binds ubiquitinated proteins and is necessary for the export of misfolded proteins from the ER to the cytoplasm, where they are degraded by the proteasome. The NPLOC4-UFD1-VCP complex regulates spindle disassembly at the end of mitosis and is necessary for the formation of a closed nuclear envelope. Regulates E3 ubiquitin-protein ligase activity of RNF19A. Component of the VCP/p97-AMFR/gp78 complex that participates in the final step of the sterol-mediated ubiquitination and endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Involved in endoplasmic reticulum stress-induced pre-emptive quality control, a mechanism that selectively attenuates the translocation of newly synthesized proteins into the endoplasmic reticulum and reroutes them to the cytosol for proteasomal degradation (PubMed:26565908). Also involved in DNA damage response: recruited to double-strand breaks (DSBs) sites in a RNF8- and RNF168-dependent manner and promotes the recruitment of TP53BP1 at DNA damage sites (PubMed:22020440, PubMed:22120668). Recruited to stalled replication forks by SPRTN: may act by mediating extraction of DNA polymerase eta (POLH) to prevent excessive translesion DNA synthesis and limit the incidence of mutations induced by DNA damage (PubMed:23042607, PubMed:23042605). Required for cytoplasmic retrotranslocation of stressed/damaged mitochondrial outer-membrane proteins and their subsequent proteasomal degradation (PubMed:16186510, PubMed:21118995). Essential for the maturation of ubiquitin-containing autophagosomes and the clearance of ubiquitinated protein by autophagy (PubMed:20104022). Acts as a negative regulator of type I interferon production by interacting with DDX58/RIG-I: interaction takes place when DDX58/RIG-I is ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit RNF125 and promote ubiquitination and degradation of DDX58/RIG-I (PubMed:26471729).</text>
</comment>
<comment type="catalytic activity">
<text evidence="71">ATP + H(2)O = ADP + phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="25 26 29 30 31 34 35 36 38 40 41 42 43 44 45 46 47 48 49 51 52 55 56 57 59 60 62 63 65 66 68 71 74">Homohexamer. Forms a ring-shaped particle of 12.5 nm diameter, that displays 6-fold radial symmetry. Part of a ternary complex containing STX5A, NSFL1C and VCP. NSFL1C forms a homotrimer that binds to one end of a VCP homohexamer. The complex binds to membranes enriched in phosphatidylethanolamine-containing lipids and promotes Golgi membrane fusion. Binds to a heterodimer of NPLOC4 and UFD1, binding to this heterodimer inhibits Golgi-membrane fusion (PubMed:26471729). Interaction with VCIP135 leads to dissociation of the complex via ATP hydrolysis by VCP. Part of a ternary complex containing NPLOC4, UFD1 and VCP. Interacts with NSFL1C-like protein p37; the complex has membrane fusion activity and is required for Golgi and endoplasmic reticulum biogenesis. Interacts with SELENOS and SYVN1, as well as with DERL1, DERL2 and DERL3; which probably transfer misfolded proteins from the ER to VCP. Interacts with SVIP. Component of a complex required to couple retrotranslocation, ubiquitination and deglycosylation composed of NGLY1, SAKS1, AMFR, VCP and RAD23B. Directly interacts with UBXN4 and RNF19A. Interacts with CASR. Interacts with UBXN6, UBE4B and YOD1. Interacts with clathrin. Interacts with RNF103. Interacts with TRIM13 and TRIM21. Component of a VCP/p97-AMFR/gp78 complex that participates in the final step of the endoplasmic reticulum-associated degradation (ERAD) of HMGCR. Interacts directly with AMFR/gp78 (via its VIM). Interacts with RHBDD1 (via C-terminal domain). Interacts with SPRTN; leading to recruitment to stalled replication forks (PubMed:23042607, PubMed:23042605). Interacts with WASHC5. Interacts with UBOX5. Interacts (via N-terminus) with UBXN7, UBXN8, and probably several other UBX domain-containing proteins (via UBX domains); the interactions are mutually exclusive with VIM-dependent interactions such as those with AMFR and SELENOS. Forms a complex with UBQLN1 and UBXN4. Interacts (via the PIM motif) with RNF31 (via the PUB domain) (PubMed:24726327). Interacts with DDX58/RIG-I and RNF125; interaction takes place when DDX58/RIG-I is ubiquitinated via 'Lys-63'-linked ubiquitin on its CARD domains, leading to recruit RNF125 and promote ubiquitination and degradation of DDX58/RIG-I (PubMed:26471729). Interacts with BAG6 (PubMed:21636303).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-355164"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1046367">
<id>Q9UKV5</id>
<label>AMFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1993677">
<id>Q9BZE9</id>
<label>ASPSCR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-946046">
<id>P54252</id>
<label>ATXN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-946068">
<id>P54252-1</id>
<label>ATXN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1180783">
<id>O96017</id>
<label>CHEK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1215612">
<id>O94868</id>
<label>FCHSD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-721577">
<id>Q9UNZ2</id>
<label>NSFL1C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1047946">
<id>P26045</id>
<label>PTPN3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-7931266">
<id>B1AQ61</id>
<label>UBE4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1993668">
<id>P68543</id>
<label>UBXN2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-723441">
<id>Q92575</id>
<label>UBXN4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1993899">
<id>Q9BZV1</id>
<label>UBXN6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-1993627">
<id>O94888</id>
<label>UBXN7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355164"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytosol</location>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Present in the neuronal hyaline inclusion bodies specifically found in motor neurons from amyotrophic lateral sclerosis patients. Present in the Lewy bodies specifically found in neurons from Parkinson disease patients. Recruited to the cytoplasmic surface of the endoplasmic reticulum via interaction with AMFR/gp78. Following DNA double-strand breaks, recruited to the sites of damage. Recruited to stalled replication forks via interaction with SPRTN.</text>
</comment>
<comment type="domain">
<text evidence="68">The PIM (PUB-interaction motif) motif mediates interaction with the PUB domain of RNF31.</text>
</comment>
<comment type="PTM">
<text evidence="25">Phosphorylated by tyrosine kinases in response to T-cell antigen receptor activation. Phosphorylated in mitotic cells.</text>
</comment>
<comment type="PTM">
<text evidence="33">ISGylated.</text>
</comment>
<comment type="PTM">
<text evidence="64 67">Methylation at Lys-315 catalyzed by VCPKMT is increased in the presence of ASPSCR1. Lys-315 methylation may decrease ATPase activity.</text>
</comment>
<comment type="disease" evidence="28 32 37 39 50 51 67 69 70 73">
<disease id="DI-01817">
<name>Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1</name>
<acronym>IBMPFD1</acronym>
<description>An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.</description>
<dbReference type="MIM" id="167320"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="54 67">
<disease id="DI-03119">
<name>Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia</name>
<acronym>ALS14</acronym>
<description>A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of the cases. Patients with ALS14 may develop frontotemporal dementia.</description>
<dbReference type="MIM" id="613954"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="69 70">
<disease id="DI-04589">
<name>Charcot-Marie-Tooth disease 2Y</name>
<acronym>CMT2Y</acronym>
<description>An autosomal dominant, axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.</description>
<dbReference type="MIM" id="616687"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="76">Belongs to the AAA ATPase family.</text>
</comment>
<comment type="caution">
<text evidence="77 78">It is unclear how it participates in the recruitment of TP53BP1 at DNA damage sites. According to a first report, participates in the recruitment of TP53BP1 by promoting ubiquitination and removal of L3MBTL1 from DNA damage sites (PubMed:22120668). According to a second report, it acts by removing 'Lys-48'-linked ubiquitination from sites of DNA damage (PubMed:22020440).</text>
</comment>
<dbReference type="EC" id="3.6.4.6" evidence="71"/>
<dbReference type="EMBL" id="AC004472">
<property type="protein sequence ID" value="AAC07984.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF100752">
<property type="protein sequence ID" value="AAD43016.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312310">
<property type="protein sequence ID" value="BAG35235.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353795">
<property type="protein sequence ID" value="CAH70993.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58404.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110913">
<property type="protein sequence ID" value="AAI10914.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC121794">
<property type="protein sequence ID" value="AAI21795.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z70768">
<property type="protein sequence ID" value="CAA94809.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6573.1"/>
<dbReference type="PIR" id="T02243">
<property type="entry name" value="T02243"/>
</dbReference>
<dbReference type="RefSeq" id="NP_009057.1">
<property type="nucleotide sequence ID" value="NM_007126.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.529782"/>
<dbReference type="PDB" id="3EBB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="E/F/G/H=797-806"/>
</dbReference>
<dbReference type="PDB" id="3HU1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A/B/C/D/E/F=1-481"/>
</dbReference>
<dbReference type="PDB" id="3HU2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B/C/D/E/F=1-481"/>
</dbReference>
<dbReference type="PDB" id="3HU3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=1-481"/>
</dbReference>
<dbReference type="PDB" id="3QC8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=21-196"/>
</dbReference>
<dbReference type="PDB" id="3QQ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=2-187"/>
</dbReference>
<dbReference type="PDB" id="3QQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=2-187"/>
</dbReference>
<dbReference type="PDB" id="3QWZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1-208"/>
</dbReference>
<dbReference type="PDB" id="3TIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1-187"/>
</dbReference>
<dbReference type="PDB" id="4KDI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A/B=21-196"/>
</dbReference>
<dbReference type="PDB" id="4KDL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=21-196"/>
</dbReference>
<dbReference type="PDB" id="4KLN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A/B/C/D/E/F=1-481"/>
</dbReference>
<dbReference type="PDB" id="4KO8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=1-481"/>
</dbReference>
<dbReference type="PDB" id="4KOD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=1-481"/>
</dbReference>
<dbReference type="PDB" id="4P0A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="B/D=797-806"/>
</dbReference>
<dbReference type="PDB" id="5B6C">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=21-191"/>
</dbReference>
<dbReference type="PDB" id="5C18">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C/D/E/F=2-806"/>
</dbReference>
<dbReference type="PDB" id="5C19">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.20"/>
<property type="chains" value="A/B/C/D/E/F=2-806"/>
</dbReference>
<dbReference type="PDB" id="5C1A">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=2-806"/>
</dbReference>
<dbReference type="PDB" id="5C1B">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.08"/>
<property type="chains" value="A/B/C/D/E/F=2-806"/>
</dbReference>
<dbReference type="PDB" id="5DYG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-460"/>
</dbReference>
<dbReference type="PDB" id="5DYI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.71"/>
<property type="chains" value="A/B/C/D/E/F/G/H/I/J/K/L=1-481"/>
</dbReference>
<dbReference type="PDB" id="5EPP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="A=21-199"/>
</dbReference>
<dbReference type="PDB" id="5FTJ">
<property type="method" value="EM"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D/E/F=1-806"/>
</dbReference>
<dbReference type="PDB" id="5FTK">
<property type="method" value="EM"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D/E/F=1-806"/>
</dbReference>
<dbReference type="PDB" id="5FTL">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C/D/E/F=1-806"/>
</dbReference>
<dbReference type="PDB" id="5FTM">
<property type="method" value="EM"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B/C/D/E/F=1-806"/>
</dbReference>
<dbReference type="PDB" id="5FTN">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B/C/D/E/F=1-806"/>
</dbReference>
<dbReference type="PDB" id="5GLF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/C/E/G=21-199"/>
</dbReference>
<dbReference type="PDB" id="5IFS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.46"/>
<property type="chains" value="B/D=1-481"/>
</dbReference>
<dbReference type="PDB" id="5IFW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="B=2-806"/>
</dbReference>
<dbReference type="PDB" id="5X4L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=23-196"/>
</dbReference>
<dbReference type="PDBsum" id="3EBB"/>
<dbReference type="PDBsum" id="3HU1"/>
<dbReference type="PDBsum" id="3HU2"/>
<dbReference type="PDBsum" id="3HU3"/>
<dbReference type="PDBsum" id="3QC8"/>
<dbReference type="PDBsum" id="3QQ7"/>
<dbReference type="PDBsum" id="3QQ8"/>
<dbReference type="PDBsum" id="3QWZ"/>
<dbReference type="PDBsum" id="3TIW"/>
<dbReference type="PDBsum" id="4KDI"/>
<dbReference type="PDBsum" id="4KDL"/>
<dbReference type="PDBsum" id="4KLN"/>
<dbReference type="PDBsum" id="4KO8"/>
<dbReference type="PDBsum" id="4KOD"/>
<dbReference type="PDBsum" id="4P0A"/>
<dbReference type="PDBsum" id="5B6C"/>
<dbReference type="PDBsum" id="5C18"/>
<dbReference type="PDBsum" id="5C19"/>
<dbReference type="PDBsum" id="5C1A"/>
<dbReference type="PDBsum" id="5C1B"/>
<dbReference type="PDBsum" id="5DYG"/>
<dbReference type="PDBsum" id="5DYI"/>
<dbReference type="PDBsum" id="5EPP"/>
<dbReference type="PDBsum" id="5FTJ"/>
<dbReference type="PDBsum" id="5FTK"/>
<dbReference type="PDBsum" id="5FTL"/>
<dbReference type="PDBsum" id="5FTM"/>
<dbReference type="PDBsum" id="5FTN"/>
<dbReference type="PDBsum" id="5GLF"/>
<dbReference type="PDBsum" id="5IFS"/>
<dbReference type="PDBsum" id="5IFW"/>
<dbReference type="PDBsum" id="5X4L"/>
<dbReference type="ProteinModelPortal" id="P55072"/>
<dbReference type="SMR" id="P55072"/>
<dbReference type="BioGrid" id="113258">
<property type="interactions" value="604"/>
</dbReference>
<dbReference type="DIP" id="DIP-33543N"/>
<dbReference type="IntAct" id="P55072">
<property type="interactions" value="95"/>
</dbReference>
<dbReference type="MINT" id="MINT-272884"/>
<dbReference type="STRING" id="9606.ENSP00000351777"/>
<dbReference type="BindingDB" id="P55072"/>
<dbReference type="ChEMBL" id="CHEMBL1075145"/>
<dbReference type="DrugBank" id="DB04395">
<property type="generic name" value="Phosphoaminophosphonic Acid-Adenylate Ester"/>
</dbReference>
<dbReference type="TCDB" id="3.A.16.1.1">
<property type="family name" value="the endoplasmic reticular retrotranslocon (er-rt) family"/>
</dbReference>
<dbReference type="iPTMnet" id="P55072"/>
<dbReference type="PhosphoSitePlus" id="P55072"/>
<dbReference type="SwissPalm" id="P55072"/>
<dbReference type="BioMuta" id="VCP"/>
<dbReference type="DMDM" id="6094447"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P55072"/>
<dbReference type="OGP" id="P55072"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00022774"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P55072"/>
<dbReference type="EPD" id="P55072"/>
<dbReference type="PaxDb" id="P55072"/>
<dbReference type="PeptideAtlas" id="P55072"/>
<dbReference type="PRIDE" id="P55072"/>
<dbReference type="TopDownProteomics" id="P55072"/>
<dbReference type="Ensembl" id="ENST00000358901">
<property type="protein sequence ID" value="ENSP00000351777"/>
<property type="gene ID" value="ENSG00000165280"/>
</dbReference>
<dbReference type="GeneID" id="7415"/>
<dbReference type="KEGG" id="hsa:7415"/>
<dbReference type="CTD" id="7415"/>
<dbReference type="DisGeNET" id="7415"/>
<dbReference type="GeneCards" id="VCP"/>
<dbReference type="GeneReviews" id="VCP"/>
<dbReference type="HGNC" id="HGNC:12666">
<property type="gene designation" value="VCP"/>
</dbReference>
<dbReference type="HPA" id="CAB005593"/>
<dbReference type="HPA" id="HPA012728"/>
<dbReference type="HPA" id="HPA012814"/>
<dbReference type="MalaCards" id="VCP"/>
<dbReference type="MIM" id="167320">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601023">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613954">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616687">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P55072"/>
<dbReference type="OpenTargets" id="ENSG00000165280"/>
<dbReference type="Orphanet" id="329478">
<property type="disease" value="Adult-onset distal myopathy due to VCP mutation"/>
</dbReference>
<dbReference type="Orphanet" id="803">
<property type="disease" value="Amyotrophic lateral sclerosis"/>
</dbReference>
<dbReference type="Orphanet" id="275864">
<property type="disease" value="Behavioral variant of frontotemporal dementia"/>
</dbReference>
<dbReference type="Orphanet" id="275872">
<property type="disease" value="Frontotemporal dementia with motor neuron disease"/>
</dbReference>
<dbReference type="Orphanet" id="52430">
<property type="disease" value="Inclusion body myopathy with Paget disease of bone and frontotemporal dementia"/>
</dbReference>
<dbReference type="Orphanet" id="100070">
<property type="disease" value="Progressive non-fluent aphasia"/>
</dbReference>
<dbReference type="Orphanet" id="100069">
<property type="disease" value="Semantic dementia"/>
</dbReference>
<dbReference type="Orphanet" id="329475">
<property type="disease" value="Spastic paraplegia - Paget disease of bone"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37289"/>
<dbReference type="eggNOG" id="KOG0730">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0464">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00860000133780"/>
<dbReference type="HOGENOM" id="HOG000223224"/>
<dbReference type="HOVERGEN" id="HBG001226"/>
<dbReference type="InParanoid" id="P55072"/>
<dbReference type="KO" id="K13525"/>
<dbReference type="OMA" id="MADSKGD"/>
<dbReference type="OrthoDB" id="EOG091G024K"/>
<dbReference type="PhylomeDB" id="P55072"/>
<dbReference type="TreeFam" id="TF300542"/>
<dbReference type="Reactome" id="R-HSA-110320">
<property type="pathway name" value="Translesion Synthesis by POLH"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371511">
<property type="pathway name" value="HSF1 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-382556">
<property type="pathway name" value="ABC-family proteins mediated transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-532668">
<property type="pathway name" value="N-glycan trimming in the ER and Calnexin/Calreticulin cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5358346">
<property type="pathway name" value="Hedgehog ligand biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5362768">
<property type="pathway name" value="Hh mutants that don't undergo autocatalytic processing are degraded by ERAD"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5678895">
<property type="pathway name" value="Defective CFTR causes cystic fibrosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689877">
<property type="pathway name" value="Josephin domain DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8876725">
<property type="pathway name" value="Protein methylation"/>
</dbReference>
<dbReference type="SignaLink" id="P55072"/>
<dbReference type="SIGNOR" id="P55072"/>
<dbReference type="ChiTaRS" id="VCP">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P55072"/>
<dbReference type="GeneWiki" id="Valosin-containing_protein"/>
<dbReference type="GenomeRNAi" id="7415"/>
<dbReference type="PRO" id="PR:P55072"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000165280"/>
<dbReference type="CleanEx" id="HS_VCP"/>
<dbReference type="ExpressionAtlas" id="P55072">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P55072">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:1904949">
<property type="term" value="C:ATPase complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035578">
<property type="term" value="C:azurophil granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036513">
<property type="term" value="C:Derlin-1 retrotranslocation complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1904813">
<property type="term" value="C:ficolin-1-rich granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000502">
<property type="term" value="C:proteasome complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035861">
<property type="term" value="C:site of double-strand break"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034098">
<property type="term" value="C:VCP-NPL4-UFD1 AAA ATPase complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990730">
<property type="term" value="C:VCP-NSFL1C complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043531">
<property type="term" value="F:ADP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016887">
<property type="term" value="F:ATPase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904288">
<property type="term" value="F:BAT3 complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035800">
<property type="term" value="F:deubiquitinase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0036435">
<property type="term" value="F:K48-linked polyubiquitin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042288">
<property type="term" value="F:MHC class I protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031593">
<property type="term" value="F:polyubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044389">
<property type="term" value="F:ubiquitin-like protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1990381">
<property type="term" value="F:ubiquitin-specific protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070842">
<property type="term" value="P:aggresome assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046034">
<property type="term" value="P:ATP metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097352">
<property type="term" value="P:autophagosome maturation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030968">
<property type="term" value="P:endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006888">
<property type="term" value="P:ER to Golgi vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071712">
<property type="term" value="P:ER-associated misfolded protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036503">
<property type="term" value="P:ERAD pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070987">
<property type="term" value="P:error-free translesion synthesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045184">
<property type="term" value="P:establishment of protein localization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072389">
<property type="term" value="P:flavin adenine dinucleotide catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006734">
<property type="term" value="P:NADH metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2001171">
<property type="term" value="P:positive regulation of ATP biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903007">
<property type="term" value="P:positive regulation of Lys63-specific deubiquitinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010918">
<property type="term" value="P:positive regulation of mitochondrial membrane potential"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903862">
<property type="term" value="P:positive regulation of oxidative phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031334">
<property type="term" value="P:positive regulation of protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903006">
<property type="term" value="P:positive regulation of protein K63-linked deubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010498">
<property type="term" value="P:proteasomal protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006457">
<property type="term" value="P:protein folding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034214">
<property type="term" value="P:protein hexamerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006479">
<property type="term" value="P:protein methylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018279">
<property type="term" value="P:protein N-linked glycosylation via asparagine"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903715">
<property type="term" value="P:regulation of aerobic respiration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030970">
<property type="term" value="P:retrograde protein transport, ER to cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019985">
<property type="term" value="P:translesion synthesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055085">
<property type="term" value="P:transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030433">
<property type="term" value="P:ubiquitin-dependent ERAD pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019079">
<property type="term" value="P:viral genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="Gene3D" id="3.10.330.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003593">
<property type="entry name" value="AAA+_ATPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR005938">
<property type="entry name" value="AAA_ATPase_CDC48"/>
</dbReference>
<dbReference type="InterPro" id="IPR009010">
<property type="entry name" value="Asp_de-COase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003959">
<property type="entry name" value="ATPase_AAA_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR003960">
<property type="entry name" value="ATPase_AAA_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR004201">
<property type="entry name" value="Cdc48_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR029067">
<property type="entry name" value="CDC48_domain_2-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR003338">
<property type="entry name" value="CDC4_N-term_subdom"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR015415">
<property type="entry name" value="Vps4_C"/>
</dbReference>
<dbReference type="Pfam" id="PF00004">
<property type="entry name" value="AAA"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF02933">
<property type="entry name" value="CDC48_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02359">
<property type="entry name" value="CDC48_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09336">
<property type="entry name" value="Vps4_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00382">
<property type="entry name" value="AAA"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM01072">
<property type="entry name" value="CDC48_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01073">
<property type="entry name" value="CDC48_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50692">
<property type="entry name" value="SSF50692"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54585">
<property type="entry name" value="SSF54585"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01243">
<property type="entry name" value="CDC48"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00674">
<property type="entry name" value="AAA"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0036">Amyotrophic lateral sclerosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0446">Lipid-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="initiator methionine" description="Removed" evidence="18 19 21 22 24 27 75">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Transitional endoplasmic reticulum ATPase" id="PRO_0000084572">
<location>
<begin position="2"/>
<end position="806"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="51">
<location>
<begin position="247"/>
<end position="253"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="26">
<location>
<begin position="521"/>
<end position="526"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with UBXN6" evidence="45">
<location>
<begin position="797"/>
<end position="806"/>
</location>
</feature>
<feature type="short sequence motif" description="PIM motif" evidence="68">
<location>
<begin position="802"/>
<end position="806"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="51">
<location>
<position position="348"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="51">
<location>
<position position="384"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="18 19 21 22 24 75">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17 18 21 23">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="37"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6,N6-trimethyllysine; by VCPKMT" evidence="64 67">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="17">
<location>
<position position="436"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="462"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="26">
<location>
<position position="502"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="26">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="26">
<location>
<position position="668"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="26">
<location>
<position position="668"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="702"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="26">
<location>
<position position="754"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="770"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="775"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="787"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="26">
<location>
<position position="805"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; cultured cells expressing the mutant protein show a marked general increase in the level of ubiquitin-conjugated proteins and impaired protein degradation through the endoplasmic reticulum-associated degradation (ERAD) pathway; shows strongly reduced affinity for ADP and increased affinity for ATP; abolishes enhancement of K-315 methylation by ASPSCR1; dbSNP:rs121909332." id="VAR_033016" evidence="28 39 51">
<original>R</original>
<variation>G</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Y; increased ATPase activity; dbSNP:rs864309502." id="VAR_076464" evidence="70">
<original>G</original>
<variation>E</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; unknown pathological significance." id="VAR_076465" evidence="73">
<original>I</original>
<variation>F</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; also in one patient without evidence of Paget disease of the bone; dbSNP:rs121909330." id="VAR_033017" evidence="28 32">
<original>R</original>
<variation>C</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS14 and IBMPFD1; ALS14 patients do not manifest frontotemporal dementia; properly assembles into a hexameric structure; cultured cells expressing the mutant protein show a marked general increase in the level of ubiquitin-conjugated proteins and impaired protein degradation through the endoplasmic reticulum-associated degradation (ERAD) pathway; shows strongly reduced affinity for ADP and increased affinity for ATP; shows normal ATPase activity according to PubMed:16321991 while according to PubMed:25878907 and PubMed:25125609 shows increased ATPase activity; no defect in ubiquitin-dependent protein degradation by the proteasome; impaired autophagic function; defective maturation of ubiquitin-containing autophagosomes; dbSNP:rs121909329." id="VAR_033018" evidence="28 39 50 51 54 67 69 70">
<original>R</original>
<variation>H</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; dbSNP:rs121909329." id="VAR_033019" evidence="28">
<original>R</original>
<variation>P</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; impaired autophagic function." id="VAR_076466" evidence="50">
<original>R</original>
<variation>S</variation>
<location>
<position position="155"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS14; dbSNP:rs387906789." id="VAR_065910" evidence="54 67">
<original>R</original>
<variation>G</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; without frontotemporal dementia; abolishes enhancement of K-315 methylation by ASPSCR1; dbSNP:rs121909335." id="VAR_033020" evidence="37">
<original>R</original>
<variation>H</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2Y; normal ATPase activity; impaired autophagic function; dbSNP:rs864309501." id="VAR_076467" evidence="69">
<original>E</original>
<variation>K</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS14 and IBMPFD1; abolishes enhancement of K-315 methylation by ASPSCR1; dbSNP:rs121909334." id="VAR_033021" evidence="28 54 67">
<original>R</original>
<variation>Q</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; increased ATPase activity." id="VAR_076468" evidence="70">
<original>L</original>
<variation>W</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In IBMPFD1; increased ATPase activity; no defect in ubiquitin-dependent protein degradation by the proteasome; impaired autophagic function; defect in maturation of ubiquitin-containing autophagosomes; dbSNP:rs121909331." id="VAR_033022" evidence="28 50 69 70">
<original>A</original>
<variation>E</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In ALS14; ALS14 patients do not show frontotemporal dementia; dbSNP:rs387906790." id="VAR_065911" evidence="54">
<original>D</original>
<variation>N</variation>
<location>
<position position="592"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NPLOC4; when associated with A-110." evidence="71">
<original>FRGD</original>
<variation>ARGA</variation>
<location>
<begin position="52"/>
<end position="55"/>
</location>
</feature>
<feature type="mutagenesis site" description="Minor effect on affinity for ATP and ADP." evidence="51">
<original>R</original>
<variation>A</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly increased affinity for ATP. Strongly reduced affinity for ADP." evidence="51">
<original>R</original>
<variation>A</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with NPLOC4; when associated with 52-A--A-55." evidence="71">
<original>Y</original>
<variation>A</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ERAD degradation of HMGCR and does not inhibit interaction with RHBDD1; when associated with Q-524." evidence="34 62">
<original>K</original>
<variation>Q</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="mutagenesis site" description="Defect in ubiquitin-dependent protein degradation by the proteasome; when associated with Q-578." evidence="50 71">
<original>E</original>
<variation>Q</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by VCPKMT." evidence="64">
<original>K</original>
<variation>A</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by VCPKMT." evidence="64">
<original>R</original>
<variation>A</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by VCPKMT." evidence="64">
<original>E</original>
<variation>A</variation>
<location>
<position position="314"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly impairs methylation by VCPKMT." evidence="64">
<location>
<position position="314"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes methylation by VCPKMT." evidence="64 67">
<original>K</original>
<variation>L</variation>
<variation>Q</variation>
<variation>R</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by VCPKMT." evidence="64">
<original>T</original>
<variation>A</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by VCPKMT." evidence="64">
<original>H</original>
<variation>A</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect methylation by VCPKMT." evidence="64">
<original>G</original>
<variation>A</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs catalytic activity of RNF19A toward SOD1 mutant. Does not inhibit interaction with RHBDD1; when associated with A-251." evidence="31 34 62">
<original>K</original>
<variation>A</variation>
<location>
<position position="524"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ERAD degradation of HMGCR; when associated with Q-251." evidence="31 34 62">
<original>K</original>
<variation>Q</variation>
<location>
<position position="524"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit interaction with RHBDD1. Defect in ubiquitin-dependent protein degradation by the proteasome; when associated with Q-305." evidence="50 62 71">
<original>E</original>
<variation>Q</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAI21795." ref="6" evidence="76">
<original>D</original>
<variation>H</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG35235." ref="3" evidence="76">
<original>K</original>
<variation>I</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="15"/>
<end position="17"/>
</location>
</feature>
<feature type="helix" evidence="16">
<location>
<begin position="22"/>
<end position="24"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="25"/>
<end position="29"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="43"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="53"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="56"/>
<end position="60"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="66"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="86"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="93"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="99"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="112"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="120"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="126"/>
<end position="128"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="130"/>
<end position="133"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="135"/>
<end position="139"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="140"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="144"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="151"/>
<end position="154"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="157"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="161"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="191"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="210"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="221"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="227"/>
<end position="233"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="246"/>
<end position="250"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="251"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="263"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="271"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="281"/>
<end position="295"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="298"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="306"/>
<end position="308"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="319"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="341"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="355"/>
<end position="358"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="360"/>
<end position="362"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="365"/>
<end position="368"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="374"/>
<end position="385"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="388"/>
<end position="390"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="396"/>
<end position="401"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="408"/>
<end position="424"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="425"/>
<end position="429"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="432"/>
<end position="436"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="439"/>
<end position="444"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="449"/>
<end position="457"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="458"/>
<end position="461"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="462"/>
<end position="468"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="476"/>
<end position="478"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="483"/>
<end position="498"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="500"/>
<end position="505"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="513"/>
<end position="517"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="524"/>
<end position="534"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="538"/>
<end position="542"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="544"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="559"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="571"/>
<end position="578"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="581"/>
<end position="586"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="588"/>
<end position="590"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="599"/>
<end position="609"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="613"/>
<end position="624"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="626"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="631"/>
<end position="634"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="635"/>
<end position="639"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="641"/>
<end position="644"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="650"/>
<end position="661"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="662"/>
<end position="664"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="672"/>
<end position="678"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="684"/>
<end position="706"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="722"/>
<end position="724"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="735"/>
<end position="741"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="749"/>
<end position="762"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="763"/>
<end position="765"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HU1"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QQ8"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KDI"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KDL"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KLN"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KO8"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5B6C"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5C1B"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DYG"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FTJ"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FTK"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FTL"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FTM"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5FTN"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IFS"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IFW"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P46462"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01853"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12665801"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15034582"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15215856"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15362974"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15456787"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15732117"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16139798"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16168377"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16186509"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16186510"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247064"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16289116"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16321991"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16449189"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16513638"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16968747"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17314412"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18022694"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18656546"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18675248"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19818707"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19822669"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19887378"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20104022"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20512113"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20833645"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21118995"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21145000"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21636303"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21914798"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21949850"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22020440"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22120668"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22537386"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22607976"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22795130"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22902628"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22948820"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23042605"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23042607"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23349634"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24726327"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25125609"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25878907"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26471729"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26565908"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27209344"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8413590"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="76" type="ECO:0000305"/>
<evidence key="77" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22020440"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22120668"/>
</source>
</evidence>
<sequence length="806" mass="89322" checksum="501B721D3A77BA8A" modified="2007-01-23" version="4">
MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLK
GKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPID
DTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDT
VIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRG
ILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAI
IFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRF
GRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAAL
QAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIG
GLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFI
SIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRV
INQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKAN
LRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAM
EVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGG
AGPSQGSGGGTGGSVYTEDNDDDLYG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>